Altınbaş, BurçinGüvenç-Bayram, GökçenYalçın, Murat2024-06-042024-06-042021-03-010006-89931872-6240https://doi.org/10.1016/j.brainres.2020.147239https://www.sciencedirect.com/science/article/pii/S0006899320305977https://hdl.handle.net/11452/41712Previously it was reported that central orexin (OX) and arachidonic acid (AA) signaling pathways played an active role in the control of the cardiovascular system. It was also reported that they have exhibited their cardiovascular control role by using similar central or peripheral mechanisms. However, there has been no study demonstrating the interaction between OX and AA signaling pathways in terms of cardiovascular control. The current study was designed to investigate the possible mediation of the central cyclooxygenase (COX) and lipoxygenase (LOX) pathways in OX-induced cardiovascular effects in the rats.Intracerebroventricular injection of OX increased blood pressure and heart rate in a dose-dependent manner in normotensive male Sprague Dawley rats. Moreover, the microdialysis study revealed that intracerebroventricular injected OX caused a time-dependent increase in the extracellular total prostaglandin concentrations in the posterior hypothalamus. Interestingly, central pretreatment with a non-selective COX inhibitor, ibuprofen, or a non-selective LOX inhibitor, nordihydroguaiaretic acid, partially reversed pressor and tachycardic cardiovascular responses evoked by central administration of OX.In summary, our findings show that the central treatment with OX causes pressor and tachycardic cardiovascular responses along with an increase in posterior hypothalamic extracellular total prostaglandin concentrations. Furthermore, our results also demonstrate that central COX and LOX pathways mediate, at least in part, centrally administered OX-evoked pressor and tachycardic responses, as well.eninfo:eu-repo/semantics/closedAccessRostral ventrolateral medullaPhospholipase a(2) activatorCentral histaminergic systemArachidonic-acidArterial-pressureInjected melittinHypotensive ratsThromboxane a(2)Heart-rateNeuronsOrexinCylooygenase and lipoxygenase pathwaysCardiovascular parametersIntracerebroventricularMicrodialysisPosterior hypothalamusScience & technologyLife sciences & biomedicineNeurosciencesNeurosciences & neurologyArticle00061411070000317543341214810.1016/j.brainres.2020.147239